Matthew Mosconi is associate professor of clinical child psychology and of the Life Span Institute at the University of Kansas, and director of the Kansas Center for Autism Research and Training.
![](https://www.thetransmitter.org/wp-content/uploads/2018/03/Picture.2015.KU_.MosconiCC.jpg)
Matthew Mosconi
Associate professor
University of Kansas
From this contributor
New tool may speed up drugs to ease need for sameness in autism
Using a new task to test resistance to change in autism, we are developing leads for treatments for this troublesome trait.
![](https://www.thetransmitter.org/wp-content/uploads/2018/03/201803-MosconiVP844.jpg)
New tool may speed up drugs to ease need for sameness in autism
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.